Sarepta Therapeutics (SRPT) Interest Coverage Ratio (2010 - 2022)
Sarepta Therapeutics (SRPT) posted quarterly Interest Coverage Ratio of 0.35 for Q1 2026, up 214.12% year-over-year from 0.11 in Q1 2025, and up 101.1% quarter-over-quarter from 31.63 in Q4 2025.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Interest Coverage Ratio (2010 - 2022) Analysis & Trends
Sarepta Therapeutics' Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 0.35 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 214.12% year-over-year to 0.35; the TTM figure through Mar 2026 stood at 0.04 (up 66.58% YoY), while the FY2025 annual figure was 0.63, down 223.21% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.35, up from 31.63 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 51.31 in Q4 2022, with the low at 31.63 in Q4 2025.
- The 5-year median for Interest Coverage Ratio is 0.63 (2023), against an average of 3.36.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio surged 273.95% in 2022, then plunged 658.81% in 2024.
- Sarepta Therapeutics' Interest Coverage Ratio stood at 51.31 in 2022, then tumbled by 101.24% to 0.63 in 2023, then slumped by 658.81% to 4.82 in 2024, then sank by 556.51% to 31.63 in 2025, then soared by 101.1% to 0.35 in 2026.
- Business Quant data shows SRPT's Interest Coverage Ratio at 0.35 in Q1 2026, 31.63 in Q4 2025, and 0.09 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Sarepta Therapeutics | 2.36 Bn | 1.57 Bn | 251.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -15.97 |
| Sep 30, 2022 | -8.91 |
| Jun 30, 2022 | -12.45 |
| Mar 31, 2022 | -5.03 |
| Dec 31, 2021 | -9.48 |
| Sep 30, 2021 | -1.67 |
| Jun 30, 2021 | -10.35 |
| Mar 31, 2021 | -9.70 |
| Dec 31, 2020 | -9.11 |
| Sep 30, 2020 | -9.56 |
| Jun 30, 2020 | -10.09 |
| Mar 31, 2020 | -8.67 |
| Dec 31, 2019 | -27.44 |
| Sep 30, 2019 | -16.44 |
| Jun 30, 2019 | -37.08 |
| Mar 31, 2019 | -10.41 |
| Dec 31, 2018 | 60.30 |
| Sep 30, 2018 | 10.06 |
| Jun 30, 2018 | 19.82 |
| Mar 31, 2018 | 6.85 |